A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc (2010) 3.25

A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol (2016) 2.86

Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology (2006) 2.25

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest (2001) 1.81

Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology (2004) 1.81

Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology (2004) 1.24

Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol (2013) 1.15

A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry (2004) 1.11

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics (2007) 1.09

Protein coding potential of retroviruses and other transposable elements in vertebrate genomes. Nucleic Acids Res (2005) 1.06

Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS One (2010) 1.04

Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol (2009) 1.02

Current approaches to the treatment of paraneoplastic encephalitis. Ther Adv Neurol Disord (2011) 0.99

Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am (2006) 0.96

Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy. J Neurol Neurosurg Psychiatry (2006) 0.96

Paraneoplastic antigen-like 5 gene (PNMA5) is preferentially expressed in the association areas in a primate specific manner. Cereb Cortex (2009) 0.94

Autoimmune encephalitis: A potentially reversible cause of status epilepticus, epilepsy, and cognitive decline. Ann Indian Acad Neurol (2013) 0.94

The role of genes domesticated from LTR retrotransposons and retroviruses in mammals. Front Microbiol (2012) 0.94

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci (2005) 0.93

Impaired male fertility and atrophy of seminiferous tubules caused by haploinsufficiency for Foxa3. Dev Biol (2007) 0.89

Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol (2012) 0.87

PNMA1 promotes cell growth in human pancreatic ductal adenocarcinoma. Int J Clin Exp Pathol (2014) 0.87

The importance of defining the paraneoplastic neurologic disorders. N Engl J Med (1999) 0.86

Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study. Neuro Oncol (2006) 0.86

Paraneoplastic brainstem encephalitis in a patient with malignant fibrous histiocytoma and atypical anti-neuronal antibodies. J Neurol (2004) 0.83

Modulator of Apoptosis 1: A Highly Regulated RASSF1A-Interacting BH3-Like Protein. Mol Biol Int (2012) 0.81

Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes. Mov Disord (2007) 0.81

Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J Neurol (2006) 0.80

Cognitive Function Related to the Sirh11/Zcchc16 Gene Acquired from an LTR Retrotransposon in Eutherians. PLoS Genet (2015) 0.80

Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases. Oncol Lett (2011) 0.78

Spontaneous remission of anti-Ma associated paraneoplastic mesodiencephalic and brainstem encephalitis. J Neurol (2008) 0.78

Update on paraneoplastic neurologic disorders. Oncologist (2010) 0.77

Mammalian-specific genomic functions: Newly acquired traits generated by genomic imprinting and LTR retrotransposon-derived genes in mammals. Proc Jpn Acad Ser B Phys Biol Sci (2015) 0.77

Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes. J Neurol Neurosurg Psychiatry (2011) 0.77

Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome. Neurol Sci (2011) 0.76

What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review. BMC Psychiatry (2017) 0.75

Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer. J Clin Neurol (2014) 0.75

Anti-Ta-associated paraneoplastic encephalitis with occult testicular intratubular germ-cell neoplasia. J Neurol Neurosurg Psychiatry (2007) 0.75

An LTR Retrotransposon-Derived Gene Displays Lineage-Specific Structural and Putative Species-Specific Functional Variations in Eutherians. Front Chem (2016) 0.75

An emerging problem in clinical practice: how to approach acute psychosis. Clin Pract (2011) 0.75

Discovering monotonic stemness marker genes from time-series stem cell microarray data. BMC Genomics (2015) 0.75

Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission. Front Cell Neurosci (2016) 0.75

A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 0.75

Distinct functional domains of PNMA5 mediate protein-protein interaction, nuclear localization, and apoptosis signaling in human cancer cells. J Cancer Res Clin Oncol (2016) 0.75

Anti-Ma2 antibodies in B-cell primary CNS lymphoma. J Neurol (2007) 0.75

Neuropsychological symptoms in paraneoplastic disorders. J Neurol (2007) 0.75

Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61

Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98

Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology (2010) 3.40

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell (1991) 3.33

Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12

Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology (1992) 3.11

Distribution of brain metastases. Arch Neurol (1988) 3.11

Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08

Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology (2008) 2.85

Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81

IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77

Radiation-induced dementia in patients cured of brain metastases. Neurology (1989) 2.59

Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58

Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54

Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry (2006) 2.52

Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35

Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology (2011) 2.32

Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27

Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology (2006) 2.25

Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17

Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol (2001) 2.15

Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited. J Neurol Sci (2013) 2.13

Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology (1979) 2.13

Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry (2007) 2.10

Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05

Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med (1967) 1.93

Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol (1999) 1.91

The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91

NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology (2010) 1.88

Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86

A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: report of 4 cases. Am J Surg Pathol (1999) 1.85

Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82

Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology (2004) 1.81

MRI changes in intracranial hypotension. Neurology (1993) 1.80

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79

Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79

Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology (2003) 1.79

Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis. Neurology (2010) 1.73

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73

Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange. Neurology (2000) 1.72

GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology (2011) 1.71

Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70

Radiation therapy for brain metastases. Ann Neurol (1980) 1.68

Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol (1980) 1.68

Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology (2006) 1.67

Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66

Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol (1968) 1.66

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology (1990) 1.65

Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology (2011) 1.64

Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol (1988) 1.63

Metastasis to the base of the skull: clinical findings in 43 patients. Neurology (1981) 1.61

Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59

Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol (1977) 1.58

Steroid myopathy in cancer patients. Neurology (1997) 1.57

Ataxia in epidural spinal cord compression. Neurology (1992) 1.55

Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology (1994) 1.54

Neurologic complications of carcinoid. Neurology (1986) 1.54

Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol (2007) 1.51

Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46

Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry (2008) 1.46

Chorea as a paraneoplastic complication of Hodgkin's disease. J Neurooncol (1998) 1.44

Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol (1979) 1.42

Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology (1995) 1.41

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41

Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41

The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40

Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39

[Analysis of the neurologic consultations in an oncologic hospital: contributions of neuro-oncology]. Neurologia (1999) 1.38

Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol (1995) 1.37

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36